Diabetes, Vol 44, Issue 9 1054-1058, Copyright © 1995 by American Diabetes Association

ARTICLES

Elevated levels of authentic plasma hydroperoxides in NIDDM

J Nourooz-Zadeh, J Tajaddini-Sarmadi, S McCarthy, DJ Betteridge and SP Wolff
Department of Medicine, University College London Medical School, U.K.

Using a precise technique for measuring authentic plasma lipid hydroperoxides (ROOHs), we show that individuals with non-insulin-dependent diabetes mellitus (NIDDM) have higher levels of ROOH than do control subjects. ROOHs were measured by the ferrous oxidation with xylenol orange assay coupled with the selective ROOH reductant triphenylphosphine. Formation of the ferric xylenol orange complex was determined at 560 nm and calibrated against H2O2. For 22 individuals with NIDDM, a concentration of 9.04 +/- 4.3 mumol/l (mean +/- SD) ROOH was recorded. This concentration was higher (P < 0.0005 by separate-variance t test) than that of plasma ROOHs from control subjects (3.76 +/- 2.48 mumol/l). There was no difference between concentrations of plasma malondialdehyde measured as thiobarbituric acid-reactive material (TBARM) in NIDDM or control subjects (1.00 +/- 0.70 vs. 1.21 +/- 0.62 mumol/l, respectively; P > 0.1). A trend to lower vitamin E levels in the NIDDM group (9.03 +/- 3.31 vs. 10.31 +/- 5.02 micrograms/ml in control subjects) failed to achieve significance at the 95% confidence level. Plasma ROOHs in the diabetic group did not correlate with total plasma cholesterol, triglyceride, fasting glucose, HbA1, vitamin E, or TBARM levels. These data indicate that measurement of authentic ROOHs shows NIDDM to be associated with oxidative stress, which may be unrelated to abnormalities in lipid metabolism and glycemic control.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Agarwal Anti-inflammatory effects of short-term pioglitazone therapy in men with advanced diabetic nephropathy Am J Physiol Renal Physiol, March 1, 2006; 290(3): F600 - F605. [Abstract] [Full Text] [PDF]

				D.J. Betteridge Treating dyslipidaemia in the patient with type 2 diabetes Eur. Heart J. Suppl., July 1, 2004; 6(suppl_C): C28 - C33. [Abstract] [Full Text] [PDF]

				G. Ferretti, T. Bacchetti, D. Busni, R. A. Rabini, and G. Curatola Protective Effect of Paraoxonase Activity in High-Density Lipoproteins against Erythrocyte Membranes Peroxidation: A Comparison between Healthy Subjects and Type 1 Diabetic Patients J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2957 - 2962. [Abstract] [Full Text] [PDF]

				R. P. Robertson, J. Harmon, P. O. T. Tran, and V. Poitout {beta}-Cell Glucose Toxicity, Lipotoxicity, and Chronic Oxidative Stress in Type 2 Diabetes Diabetes, February 1, 2004; 53(90001): S119 - 124. [Abstract] [Full Text]

				M. Todaro, F. Di Gaudio, M. Lavitrano, G. Stassi, and G. Papaccio Islet {beta}-Cell Apoptosis Triggered in Vivo by Interleukin-1{beta} Is Not Related to the Inducible Nitric Oxide Synthase Pathway: Evidence for Mitochondrial Function Impairment and Lipoperoxidation Endocrinology, October 1, 2003; 144(10): 4264 - 4271. [Abstract] [Full Text] [PDF]

				C. D. Gardner, S. Eguchi, C. M. Reynolds, K. Eguchi, G. D. Frank, and E. D. Motley Hydrogen Peroxide Inhibits Insulin Signaling in Vascular Smooth Muscle Cells Experimental Biology and Medicine, July 1, 2003; 228(7): 836 - 842. [Abstract] [Full Text] [PDF]

				G. Davi, F. Chiarelli, F. Santilli, M. Pomilio, S. Vigneri, A. Falco, S. Basili, G. Ciabattoni, and C. Patrono Enhanced Lipid Peroxidation and Platelet Activation in the Early Phase of Type 1 Diabetes Mellitus: Role of Interleukin-6 and Disease Duration Circulation, July 1, 2003; 107(25): 3199 - 3203. [Abstract] [Full Text] [PDF]

				R. P. Robertson, J. Harmon, P. O. Tran, Y. Tanaka, and H. Takahashi Glucose Toxicity in {beta}-Cells: Type 2 Diabetes, Good Radicals Gone Bad, and the Glutathione Connection Diabetes, March 1, 2003; 52(3): 581 - 587. [Abstract] [Full Text] [PDF]

				J. F. Keaney Jr, M. G. Larson, R. S. Vasan, P. W.F. Wilson, I. Lipinska, D. Corey, J. M. Massaro, P. Sutherland, J. A. Vita, and E. J. Benjamin Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study Arterioscler. Thromb. Vasc. Biol., March 1, 2003; 23(3): 434 - 439. [Abstract] [Full Text] [PDF]

				J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes Endocr. Rev., October 1, 2002; 23(5): 599 - 622. [Abstract] [Full Text] [PDF]

				H. Kaneda, M. Ohno, J. Taguchi, M. Togo, H. Hashimoto, K. Ogasawara, T. Aizawa, N. Ishizaka, and R. Nagai Heme Oxygenase-1 Gene Promoter Polymorphism Is Associated With Coronary Artery Disease in Japanese Patients With Coronary Risk Factors Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1680 - 1685. [Abstract] [Full Text] [PDF]

				G. Marra, P. Cotroneo, D. Pitocco, A. Manto, M. A.S. Di Leo, V. Ruotolo, S. Caputo, B. Giardina, G. Ghirlanda, and S. A. Santini Early Increase of Oxidative Stress and Reduced Antioxidant Defenses in Patients With Uncomplicated Type 1 Diabetes: A case for gender difference Diabetes Care, February 1, 2002; 25(2): 370 - 375. [Abstract] [Full Text] [PDF]

				M. Trevisan, R. Browne, M. Ram, P. Muti, J. Freudenheim, A. M. Carosella, and D. Armstrong Correlates of Markers of Oxidative Status in the General Population Am. J. Epidemiol., August 15, 2001; 154(4): 348 - 356. [Abstract] [Full Text] [PDF]

				F. S Facchini, M. H Humphreys, C. A DoNascimento, F. Abbasi, and G. M Reaven Relation between insulin resistance and plasma concentrations of lipid hydroperoxides, carotenoids, and tocopherols Am. J. Clinical Nutrition, September 1, 2000; 72(3): 776 - 779. [Abstract] [Full Text] [PDF]

				E. K. Hoogeveen, P. J. Kostense, C. Jakobs, J. M. Dekker, G. Nijpels, R. J. Heine, L. M. Bouter, and C. D. A. Stehouwer Hyperhomocysteinemia Increases Risk of Death, Especially in Type 2 Diabetes : 5-Year Follow-Up of the Hoorn Study Circulation, April 4, 2000; 101(13): 1506 - 1511. [Abstract] [Full Text] [PDF]

				L. L. Hansen, Y. Ikeda, G. S. Olsen, A. K. Busch, and L. Mosthaf Insulin Signaling Is Inhibited by Micromolar Concentrations of H2O2. EVIDENCE FOR A ROLE OF H2O2 IN TUMOR NECROSIS FACTOR alpha -MEDIATED INSULIN RESISTANCE J. Biol. Chem., August 27, 1999; 274(35): 25078 - 25084. [Abstract] [Full Text] [PDF]

				A. Tirosh, R. Potashnik, N. Bashan, and A. Rudich Oxidative Stress Disrupts Insulin-induced Cellular Redistribution of Insulin Receptor Substrate-1 and Phosphatidylinositol 3-Kinase in 3T3-L1 Adipocytes. A PUTATIVE CELLULAR MECHANISM FOR IMPAIRED PROTEIN KINASE B ACTIVATION AND GLUT4 TRANSLOCATION J. Biol. Chem., April 9, 1999; 274(15): 10595 - 10602. [Abstract] [Full Text] [PDF]

				J. F. Keaney Jr and J. Loscalzo Diabetes, Oxidative Stress, and Platelet Activation Circulation, January 19, 1999; 99(2): 189 - 191. [Full Text] [PDF]

				N. Kozlovsky, A. Rudich, R. Potashnik, Y. Ebina, T. Murakami, and N. Bashan Transcriptional Activation of the Glut1 Gene in Response to Oxidative Stress in L6 Myotubes J. Biol. Chem., December 26, 1997; 272(52): 33367 - 33372. [Abstract] [Full Text] [PDF]